VI
AGN

Versor Investments’s Allergan plc AGN Stock Holding History

Versor Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-411,965
Closed -$73M – 324
2020
Q1 		$73M Buy
411,965
+40,079
+11% +$7.55M 4.84% 10
2019
Q4 		$71.1M Sell
371,886
-5,211
-1% -$940K 3.59% 15
2019
Q3 		$63.5M Buy
377,097
+110,834
+42% +$18.1M 4.32% 11
2019
Q2 		$44.6M Buy
+266,263
New +$36.9M 2.97% 14

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Versor Investments's AGN Position: Q2 2020 in Review

Versor Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 411,965 shares — an estimated $73M sold.

Versor Investments first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $73M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Versor Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Versor Investments sold 411,965 Allergan plc shares in Q2 2020, an estimated $73M.
  • Versor Investments first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Versor Investments's Allergan plc position peaked at $73M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Versor Investments's 13F filing for Q2 2020, filed 30 Jul 2020.